Xtant Medical Statistics
Share Statistics
Xtant Medical has 139.32M
shares outstanding. The number of shares has increased by 6.75%
in one year.
| Shares Outstanding | 139.32M |
| Shares Change (YoY) | 6.75% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 71.57% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,742 |
| FTD / Avg. Volume | 0.81% |
Short Selling Information
The latest short interest is 59.92K, so 0.04% of the outstanding
shares have been sold short.
| Short Interest | 59.92K |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -3.6 and the forward
PE ratio is -71.
Xtant Medical's PEG ratio is
0.
| PE Ratio | -3.6 |
| Forward PE | -71 |
| PS Ratio | 0.5 |
| Forward PS | 0.7 |
| PB Ratio | 1.38 |
| P/FCF Ratio | -3.7 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Xtant Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35,
with a Debt / Equity ratio of 0.82.
| Current Ratio | 2.35 |
| Quick Ratio | 1 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | -4.46 |
| Debt / FCF | -2.2 |
| Interest Coverage | -2.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $540,400.92 |
| Profits Per Employee | $-75,801.84 |
| Employee Count | 217 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 1.27 |
Taxes
| Income Tax | 187K |
| Effective Tax Rate | -1.15% |
Stock Price Statistics
The stock price has increased by -1.48% in the
last 52 weeks. The beta is -0.13, so Xtant Medical's
price volatility has been lower than the market average.
| Beta | -0.13 |
| 52-Week Price Change | -1.48% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 74.5 |
| Average Volume (20 Days) | 216,073 |
Income Statement
In the last 12 months, Xtant Medical had revenue of 117.27M
and earned -16.45M
in profits. Earnings per share was -0.12.
| Revenue | 117.27M |
| Gross Profit | 68.22M |
| Operating Income | -12.07M |
| Net Income | -16.45M |
| EBITDA | -7.88M |
| EBIT | -12.1M |
| Earnings Per Share (EPS) | -0.12 |
Full Income StatementBalance Sheet
The company has 6.2M in cash and 35.14M in
debt, giving a net cash position of -28.94M.
| Cash & Cash Equivalents | 6.2M |
| Total Debt | 35.14M |
| Net Cash | -28.94M |
| Retained Earnings | -259.46M |
| Total Assets | 95.83M |
| Working Capital | 39.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -11.9M
and capital expenditures -4.11M, giving a free cash flow of -16.01M.
| Operating Cash Flow | -11.9M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | -16.01M |
| FCF Per Share | -0.12 |
Full Cash Flow StatementMargins
Gross margin is 58.17%, with operating and profit margins of -10.3% and -14.03%.
| Gross Margin | 58.17% |
| Operating Margin | -10.3% |
| Pretax Margin | -13.87% |
| Profit Margin | -14.03% |
| EBITDA Margin | -6.72% |
| EBIT Margin | -10.3% |
| FCF Margin | -13.65% |
